메뉴 건너뛰기




Volumn 94, Issue 3, 2015, Pages 279-280

Corrigendum to: Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia (European Journal of Haematology, (2015), 94, 3, (279-280), 10.1111/ejh.12454);Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; INTERLEUKIN 2;

EID: 84923266510     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.13181     Document Type: Erratum
Times cited : (4)

References (4)
  • 1
    • 84908495671 scopus 로고    scopus 로고
    • Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts
    • Michelis FV, Messner HA, Loach D, Uhm J, Gupta V, Lipton JH, Seftel MD, Kuruvilla J, Kim DD. Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts. Eur J Haematol 2014;93:273-80.
    • (2014) Eur J Haematol , vol.93 , pp. 273-280
    • Michelis, F.V.1    Messner, H.A.2    Loach, D.3    Uhm, J.4    Gupta, V.5    Lipton, J.H.6    Seftel, M.D.7    Kuruvilla, J.8    Kim, D.D.9
  • 2
    • 33745714215 scopus 로고    scopus 로고
    • Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial
    • Brune M, Castaigne S, Catalano J, et al. Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial. Blood 2006;108:88-96.
    • (2006) Blood , vol.108 , pp. 88-96
    • Brune, M.1    Castaigne, S.2    Catalano, J.3
  • 3
    • 84883554292 scopus 로고    scopus 로고
    • Immunotherapeutic strategies for relapse control in acute myeloid leukemia
    • Martner A, Thoren FB, Aurelius J, Hellstrand K. Immunotherapeutic strategies for relapse control in acute myeloid leukemia. Blood Rev 2013;27:209-16.
    • (2013) Blood Rev , vol.27 , pp. 209-216
    • Martner, A.1    Thoren, F.B.2    Aurelius, J.3    Hellstrand, K.4
  • 4
    • 84923297762 scopus 로고    scopus 로고
    • Histamine dihydrochloride and interleukin-2 for relapse prevention in AML: initial results of the Re:MISSION phase IV trial. Abstract for AACR Annual Meeting
    • Martner A, Rydström A, Riise R, Aurelius J, Brune M, Foa R, Hellstrand K, Thorén FB. Histamine dihydrochloride and interleukin-2 for relapse prevention in AML: initial results of the Re:MISSION phase IV trial. Abstract for AACR Annual Meeting 2014.
    • (2014)
    • Martner, A.1    Rydström, A.2    Riise, R.3    Aurelius, J.4    Brune, M.5    Foa, R.6    Hellstrand, K.7    Thorén, F.B.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.